semaglutide and cardiovascular outcomes in obesity SELECT Trial Semaglutide and cardiovascular outcomes by

Body Composition & Metabolic Research The downstream metabolic effects of ipamorelin-stimulated GH/IGF-1 axis activation including GH-mediated lipolysis in adipose tissue, IGF-1-mediated skeletal muscle protein synthesis, and nitrogen retention have made ipamorelin a useful tool in preclinical body composition research

Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance

Computerized platforms have been developed for continuous monitoring of food intake in lean and DIO mice and rats

Klotho was first identified as an anti-aging factor that is mainly expressed in renal tubular cells (110)